Xin Chen
Impact in
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Hepatology top 0.5%
Papers in
-
- RNA modifications and cancer 26
- PI3K/AKT/mTOR signaling in cancer 22
- Wnt/β-catenin signaling in development and cancer 19
-
- Cancer, Lipids, and Metabolism 20
- Cancer, Hypoxia, and Metabolism 17
- Co-authors
- Diego F. Calvisi (80 shared papers)Matthias Evert (45 shared papers)Frank Dombrowski (26 shared papers)Antonio Cigliano (37 shared papers)Coral Ho (11 shared papers)Silvia Ribback (31 shared papers)Randy C. Mifflin (3 shared papers)Don W. Powell (3 shared papers)
- Journals
- Hepatology (23 papers)Cancer Research (10 papers)Oncotarget (9 papers)PLoS ONE (8 papers)BMC Cancer (7 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xin Chen
363 papers receiving 12.1k citations
Xin Chen's Hit Papers
Peers
Comparison fields: 5 of 172
- Cancer Research 2.7k
- Hepatology 1.0k
- Molecular Biology 5.9k
- Cell Biology 1.3k
- Oncology 1.9k
Countries citing papers authored by Xin Chen
This map shows the geographic impact of Xin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Chen more than expected).
Fields of papers citing papers by Xin Chen
This network shows the impact of papers produced by Xin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Chen. The network helps show where Xin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 486 | |
| 2 | 2007 | 479 | |
| 3 | 2012 | 372 | |
| 4 | 2011 | 298 | |
| 5 | 2014 | 288 | |
| 6 | 2004 | 287 | |
| 7 | 2014 | 228 | |
| 8 | 2018 | 183 | |
| 9 | 2007 | 178 | |
| 10 | 2010 | 177 | |
| 11 | Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance Hit paper breakdown → | 2022 | 163 |
| 12 | 2012 | 162 | |
| 13 | 2005 | 144 | |
| 14 | 2000 | 138 | |
| 15 | 2017 | 137 | |
| 16 | 2014 | 135 | |
| 17 | 2015 | 124 | |
| 18 | 2018 | 121 | |
| 19 | 2010 | 116 | |
| 20 | 2005 | 114 |
About Xin Chen
Xin Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Surgery, having authored 383 papers that have together received 12.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (26 papers), Hippo pathway signaling and YAP/TAZ (25 papers), PI3K/AKT/mTOR signaling in cancer (22 papers), Cancer, Lipids, and Metabolism (20 papers), Liver physiology and pathology (19 papers), Wnt/β-catenin signaling in development and cancer (19 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). The work is most often cited by research in Cancer Research (2.7k citations), Hepatology (1.0k citations), Molecular Biology (5.9k citations), Cell Biology (1.3k citations) and Oncology (1.9k citations). Xin Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Diego F. Calvisi, Matthias Evert, Frank Dombrowski, Antonio Cigliano, Coral Ho, Silvia Ribback, Randy C. Mifflin, Don W. Powell, Li Che and Suet Yi Leung. Their work appears in journals such as Hepatology, Cancer Research, Oncotarget, PLoS ONE and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.